Alpha Signal Monitor - Daily Market Briefing | October 10, 2025
Daily Market Research Report
October 10, 2025
Alpha Signal Monitor
Welcome to your daily pre-market briefing. This report provides key insights on market opportunities and analyst perspectives to help identify potential alpha signals.
Today's Coverage: - IPO Calendar: Upcoming initial public offerings and market debuts - Stock Ratings: Latest analyst ratings and target prices for our watchlist
Watchlist Stocks: AAPL, MSFT, GOOGL, AMZN, NVDA, META, TSLA
This report is generated using advanced AI research capabilities with real-time market data access.
US IPO Calendar: October 10 – November 10, 2025
At a glance - Dates and terms are subject to change; issuers often set or update pricing only 7–10 days in advance. (stockanalysis.com)
Scheduled and expected pricings
| Expected date | Company (ticker) | Price range | Shares (offered) | Exchange |
|---|---|---|---|---|
| Mon, Oct 13, 2025 | Crown Reserve Acquisition Corp. I (CRACU units) | $10.00 (fixed) | 15,000,000 units | Nasdaq |
| Thu, Oct 16, 2025 | HW Electro Co., Ltd. (HWEP) | $4.00 | 4,150,000 | Nasdaq Capital Market |
| Week of Oct 27 (target Tue, Oct 28) | MapLight Therapeutics, Inc. (MPLT) | $17.00 | 14,750,000 | Nasdaq Global Market |
Deal notes and underwriters - Crown Reserve Acquisition Corp. I (CRACU) - Lead underwriter: Polaris Advisory Partners (a division of Kingswood Capital Partners) as sole bookrunner. (renaissancecapital.com) - Business: Healthcare-focused SPAC targeting pharma, medtech, medical equipment, and healthcare IT. (renaissancecapital.com) - Scheduling: Indicated to list Monday, Oct 13, 2025. (stockanalysis.com)
- HW Electro Co., Ltd. (HWEP)
- Lead underwriters: American Trust Investment Services and WestPark Capital. (sec.gov)
- Business: Japan-based seller of electric light commercial vehicles (ELEMO series), working with manufacturer Cenntro; micro-cap auto OEM entrant. (stockanalysis.com)
- Terms/sizing: $4.00 per share, 4,150,000 shares (approx. $16.6m deal). (stockanalysis.com)
- MapLight Therapeutics, Inc. (MPLT)
- Joint bookrunners: Morgan Stanley, Jefferies, Leerink Partners, Stifel. (reuters.com)
- Business: Clinical-stage biotech developing therapies for CNS disorders (lead candidate ML-007C-MA for schizophrenia and Alzheimer’s disease psychosis). (renaissancecapital.com)
- Terms/sizing and timing: 14.75m shares at $17; company guided to price/list the week of Oct 27 (target Oct 28) with Section 8(a) automatic effectiveness language noted during the shutdown. (stockanalysis.com)
Context and recent activity - Recent U.S. IPOs (this week) included Alliance Laundry Systems (ALH) and Phoenix Education Partners (PXED) on the NYSE; both priced/offered this week and began trading Oct 9. (reuters.com) - During the federal government shutdown, the SEC indicated a path for offerings to proceed via automatic effectiveness, which may influence timing for late-October deals. (reuters.com)
Notes for readers - Tickers shown for SPACs reflect units (CRACU) at IPO; common shares/warrants typically separate after the customary period. - Calendars update quickly; additional micro-cap/foreign filers listing in the U.S. may be added with little lead time. For the most current roster of scheduled dates, consult the live calendars referenced above. (stockanalysis.com)
Sources - Consolidated IPO date/terms snapshots: Stock Analysis IPO Calendar. (stockanalysis.com) - Crown Reserve profile and bookrunner: Renaissance Capital; SEC underwriting agreement. (renaissancecapital.com) - HW Electro underwriters (SEC correspondence) and company description/terms: SEC EDGAR; Stock Analysis. (sec.gov) - MapLight terms, bookrunners, and timing: Reuters; company press release; Stock Analysis; Renaissance Capital. (reuters.com) - Market/context items: Reuters (recent NYSE debuts; SEC guidance during shutdown). (reuters.com)
If you’d like this calendar delivered weekly with intraday updates and a watchlist of unscheduled filings, say “subscribe me” and note any sectors you care about most.
Stock Ratings
Error retrieving stock ratings information: Connection error.
Disclaimer
This research report is for informational purposes only and does not constitute investment advice. All information is sourced from publicly available data and should be verified independently. Past performance does not guarantee future results.
Generated on: 2025-10-10 at 11:20 UTC
Source: Alpha Signal Monitor - Automated Research System
Contact: For questions about this report, please contact your Alpha Signal Monitor administrator.
Powered by Alpha Signal Monitor | Market Intelligence Through AI